Insider Transactions Reported by 20 Insiders of FIBROGEN INC

Symbol
FGEN on Nasdaq
Location
San Francisco, CA

Insiders trading volume in the past year

FIBROGEN INC executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
RORY B. RIGGS Director $761,112 26 May 2021
Enrique A. Conterno Chief Executive Officer, Director $305,917 07 Jul 2023
Pat Cotroneo Executive Advisor & Former CFO $208,647 07 Sep 2021
Thane Wettig CEO, Director $208,202 +$84,413 +68% 06 Dec 2025
THOMAS F. KEARNS JR Director $189,821 15 Sep 2021
Mark Eisner EVP, Chief Medical Officer $121,537 06 Sep 2023
Christine Chung Svp, China Operations $115,012 06 Mar 2025
Deyaa Adib Chief Medical Officer $96,084 12 Jun 2024
Juan Graham Chief Financial Officer $56,400 06 Dec 2024
David DeLucia Chief Financial Officer $37,797 06 Dec 2025
Gerald Lema Director $34,478 05 Jun 2024
Kalevi Kurkijarvi Director $28,728 26 May 2021
Suzanne Blaug Director $22,491 05 Jun 2024
Jeffrey William Henderson Director $21,938 01 Sep 2023
Benjamin Cravatt Director $21,839 05 Jun 2024
Aoife Brennan Director $21,240 05 Jun 2024
James A. Schoeneck Director $12,296 +$105,040 30 Jun 2025
JEFFREY L. EDWARDS Director 04 Jun 2025
Michael Kauffman Director 04 Jun 2025
Maykin Ho Director 04 Jun 2025

Recent Insider Transactions by Companies or Individuals for FIBROGEN INC

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.